Varenicline Tablet, Film Coated
Product Images NDC 10135-809

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 10135-809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

808-56 (808 56)

Varenicline 0.5 mg film-coated tablets packaging label by Marlex Pharmaceuticals, Inc. The label indicates 56 tablets per package, prescription only. Includes storage instructions, dosage information, and a barcode. Highlights that each tablet contains 0.85 mg varenicline tartrate equivalent to 0.5 mg varenicline base.*

FDA Label Image

0809-56 (809 56)

Varenicline 1 mg film-coated tablets label from Marlex Pharmaceuticals, Inc. The label states the product is prescription only and contains 56 tablets. It includes storage instructions, dosage guidance notes, and the NDC 10135-0809-56 barcode.*

FDA Label Image

Varenicline Figure 1 (Vareniclinetablets Figure1.jpg)

A clustered bar chart showing the percentage outcomes from four clinical studies comparing Varenicline (various dosages and regimens) versus placebo and Bupropion SR 150 mg BID. The vertical axis represents percentage from 0% to 60%. Study 2 compares Varenicline 0.5 mg BID, 1.0 mg BID, and placebo; Study 3 compares Varenicline flexible dosing with placebo; Studies 4 and 5 compare Varenicline 1.0 mg BID, Bupropion SR 150 mg BID, and placebo. Each bar includes error bars indicating variability.*

FDA Label Image

Varenicline Figure 2 (Vareniclinetablets Figure2.jpg)

A bar chart comparing the percentage outcomes across five studies involving Varenicline and placebo or bupropion. Each study includes one or more treatment groups such as Varenicline 0.5 mg BID, Varenicline 1.0 mg BID, Varenicline Flexible, and Bupropion SR 150 mg BID, along with placebo controls. Error bars indicating variability are present for each bar.*

FDA Label Image

Varenicline Figure 3 (Vareniclinetablets Figure3.jpg)

A line graph comparing the percentage of participants continuously abstinent over nontreatment follow-up weeks between Varenicline 1.0 mg BID and placebo groups. The x-axis shows nontreatment follow-up time in weeks, and the y-axis indicates the percent continuously abstinent. Two plotted lines represent Varenicline and placebo, showing a decline over time, with Varenicline maintaining a higher abstinence rate.*

FDA Label Image

Varenicline Structure (Vareniclinetablets Structure.jpg)

Chemical structure diagram of varenicline, shown as the active ingredient varenicline tartrate. The image depicts molecular bonds and ring structures characteristic of the compound used in prescription medications under the name Varenicline.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.